COMPANY PROFILE

Robocore

Explore full profile

Intelligent personal-assistant robots powering healthcare and smart venues

Southern District, Hong KongFounded 2020Health Tech & Medtech

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Robocore

Robocore Technology, based in Hong Kong, develops advanced personal-assistant robots designed to integrate artificial intelligence with mobility and natural interaction. Its flagship product, Temi, is an autonomous service robot equipped with voice and video communication, navigation, and cloud-based AI features. The platform is tailored for professional environments such as hospitals, eldercare facilities, hotels, retail spaces, schools, and corporate offices, enabling real-time telepresence, concierge services, and smart facility management. By combining autonomous navigation, voice recognition, and IoT integration, Robocore positions itself at the intersection of healthcare technology, robotics, and enterprise solutions. The company has expanded internationally, securing partnerships with corporates and institutional clients, while leveraging a hardware-plus-software model that allows customized applications through an open development platform. Its strategic focus lies in addressing rising global demand for robotic assistance in healthcare and smart infrastructure, particularly in aging societies and AI-driven workplaces.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Southern District, Hong Kong
Employees: 14
Open positions: None listed
Dealroom signal: 26.7/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Health Care Information Technology, Telemedicine, Healthcare Technologies, IoT Automation, Service Robots, DT and LS
Technology: Artificial Intelligence, Deep Tech, Machine Learning, Autonomous & Sensor Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES D✓Equity / VC	Aug 2025	$30M	$120M	Foxconn Technology Group	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Robocore website traffic

Latest recorded traffic for Robocore is 2K monthly website visits, up 170.3% over the last three months. Robocore's team grew 0% over the past year.

Latest monthly visits2K 3-month web change+170.3% 1-year team growth0%

Monthly website visitsOct 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MEMedicubeXAutonomous medical check-ups and AI-powered disease risk prediction	Helsinki, Finland	Operational	18	$5.1M	$20M
CLClinomicAI-powered clinical decision platform for intensive care units	Aachen, Germany	Operational
HYHypervanPre-clinical medtech company developing hyperbaric systems for next-gen emergency response	New Orleans, United States	Operational
LRLoop RobotsAutomated UVC robot for environmental surface disinfection	Rijswijk, Netherlands	Operational
PTParsek Information TechnologiesParsek develops user friendly digital solutions which simplify collaboration in healthcare, with focus on outpatient care management and cross-institutional clinical collaboration	Ljubljana, Slovenia	Operational
HAHandInScanDevelops, validates and commercialises a novel hand hygiene control system for the direct and objective evaluation of hand rubbing	Budapest, Hungary	Operational
WMWSK MedicalWSK Medical is the first and only company that have developed and launched (CE-MDR class IIb approved) an AI solution that is able to detect and classify head and neck cancer during an endoscopy in real-time	Amsterdam, Netherlands	Operational
EYEyenukA global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers	Los Angeles, United States	Operational